Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAP3K2 divergent transcript (MAP3K2-DT)
- Target
- MAP3K2-DT
- Molecular classification
- Long non-coding RNA (lncRNA), Other
01
Overview
MAP3K2 divergent transcript (MAP3K2-DT) is a long non-coding RNA transcribed from the region adjacent to the MAP3K2 gene on human chromosome 2. Divergent transcripts are defined as lncRNA genes located within several hundred nucleotides of a protein-coding gene, transcribed in the opposite direction. There is currently no evidence that MAP3K2-DT encodes a protein or functions directly as a therapeutic target. Its precise biological function, disease associations, or clinical significance remain to be established. MAP3K2-DT should not be confused with MAP3K2 (Mitogen-activated protein kinase kinase kinase 2), which is a protein-coding gene with roles in signal transduction pathways, cell proliferation, and cancer, and is considered a potential therapeutic target.
- Other names
- MAP3K2-DTENST00000433673HGNC:54088NCBI Gene: 100506922Ensembl: ENSG00000236682
02
Biological functions
Other (No characterized biological function assigned)
03
Disease associations
Other (No established disease relevance documented)
Beyond the preview
Go deeper on MAP3K2 divergent transcript (MAP3K2-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MAP3K2 divergent transcript (MAP3K2-DT).